Spravato has been approved since 2019 for TRD, with its label extended the following year as a rescue therapy for adults with major depressive disorder (MDD) who were at risk of self-harm or suicide.

My practice is integrated care for adults (psychiatric medication management, psychedelic esketamine (Spravato ... happily coordinate with your other providers.

Spravato is a form of esketamine that patients take as a self-administered nasal spray under the supervision of a healthcare provider. Esketamine and ketamine are mirror molecules that together ...

Johnson & Johnson has priced its new Spravato nasal spray for treatment-resistant depression (TRD) too high to offer value for money, says a US cost-effectiveness body. The Institute for Clinical ...

Just building on everything that J&J has established with Spravato, but making it much more convenient for the patient, much more convenient for the provider. JN: Maybe just a a little more ...

Stella's Spravato therapy is a FDA-approved ketamine ... Stella Mental Health's board-certified providers and experts have treated over 9,500 people to date across 20 locations.

Living Local 15 host Jessica Williams is joined by Sean Goddard, a Psychiatric Nurse Practitioner and Owner of Viking Psychiatry, to speak about the recent approval for Spravato as a monotherapy ...

Spravato (esketamine) has possible interactions with alcohol, some other drugs, and certain supplements. Examples include Adderall and benzodiazepines such as clonazepam (Klonopin). Talk with your ...

41,366 people played the daily Crossword recently. Can you solve it faster than others?41,366 people played the daily Crossword recently. Can you solve it faster than others?

Johnson & Johnson has won Food and Drug Administration expanded approval of its Spravato nasal spray as a lone therapy for adults with treatment-resistant depression. J&J on Tuesday said the green ...